Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Congenital adrenal hyperplasia due to 11β-hydroxylase deficiency prevention
Introduction
Overview
Overview
Prenatal diagnosis of 11β-hydroxylase deficiency is conducted to prevent complication of the disease in future life and treated with prenatal dexamethasone treatment.
Primary Prevention
Primary Prevention
- Prenatal diagnosis of 11β-hydroxylase deficiency in those patients with positive family history, is conducted to prevent complication of the disease in future life and treated with prenatal dexamethasone treatment.
- The available tests are: amniotic fluid testing and oligonucleotide hybridization of deoxyribonucleic acid (DNA) obtained from chorionic villus biopsies. Utilize fetal DNA extracted from maternal blood through noninvasive methods.[1]
References
References
- ↑ Kazmi D, Bailey J, Yau M, Abu-Amer W, Kumar A, Low M, Yuen T (2017). “New developments in prenatal diagnosis of congenital adrenal hyperplasia”. J. Steroid Biochem. Mol. Biol. 165 (Pt A): 121–123. doi:10.1016/j.jsbmb.2016.06.016. PMID 27378492.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mehrian Jafarizade, M.D [2]